Skip to main navigation
  • Home
  • About Us
    • Our Story
    • Management
    • Board of Directors
    • Advisors
  • Our Science
    • Platform Technology
    • Publications
  • Our Products
    • Toca 511 & Toca FC
    • Toca 521
    • Product Pipeline
  • Healthcare Professionals
    • Professional Resources
    • Clinical Trials
      • Toca 5 Clinical Trial
      • Toca 6 Clinical Trial
      • Toca 8 Clinical Trial
      • NRG-BN006 Clinical Trial
    • Expanded Access Program
    • Investigator Sponsored Trial
  • Patients
    • Patient Stories
    • Patient Journey
    • Education
      • Glioblastoma
      • Anaplastic Astrocytoma
      • Treatments for Brain Cancer
      • Types of Brain Cancer
      • Brain Cancer Statistics
    • Blog
    • Clinical Trials – Learn More
  • Investors
    • Stock Information
      • Stock Quote
      • Stock Chart
    • News & Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Analyst Coverage
    • Financials
      • SEC Filings
      • Financial Reports
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Information Request
      • E-mail Alerts
  • Careers
  • Contact
Tocagen
  • Home
  • About Us
    • Our Story
    • Management
    • Board of Directors
    • Advisors
  • Our Science
    • Platform Technology
    • Publications
  • Our Products
    • Pipeline
    • Toca 511 & Toca FC
  • Healthcare Professionals
    • Professional Resources
    • Clinical Trials
      • Toca 5 Clinical Trial
      • Toca 6 Clinical Trial
      • Toca 8 Clinical Trial
      • NRG-BN006 Clinical Trial
    • Expanded Access Program
    • Investigator Sponsored Trial
  • Patients
    • Patient Stories
    • Patient Journey
    • Education
      • Glioblastoma
      • Anaplastic Astrocytoma
      • Treatments for Brain Cancer
      • Types of Brain Cancer
      • Brain Cancer Statistics
    • Blog
    • Clinical Trials – Learn More
  • Investors
    • Stock Information
      • Stock Quote
      • Stock Chart
    • News & Events
      • Press Releases
      • Investor Calendar
    • Presentations
    • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Report
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Information Request
      • E-mail Alerts
  • Careers
    • For Recruiters / Agencies
  • Contact

Home/ Investors/ SEC Filings
  • Stock Information
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Publications
  • SEC Filings and Financials
    • SEC Filings
    • Annual Report
    • Quarterly Results
  • Corporate Governance
  • Shareholder Services

Tools

Print Page Print Page
RSS Feeds RSS Feeds
E-mail Alerts
IR Contacts IR Contacts

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
04/10/09 D/A
Other
0001419041-09-000004.rtf
0001419041-09-000004.pdf
05/15/09 D/A
Other
0001419041-09-000005.rtf
0001419041-09-000005.pdf
06/02/09 D/A
Other
0001419041-09-000006.rtf
0001419041-09-000006.pdf
06/18/09 D
Other
0001419041-09-000007.rtf
0001419041-09-000007.pdf
11/23/09 D/A
Other
0001419041-09-000008.rtf
0001419041-09-000008.pdf
02/26/10 D
Other
0001419041-10-000001.rtf
0001419041-10-000001.pdf
03/05/10 D
Other
0001419041-10-000002.rtf
0001419041-10-000002.pdf
07/23/10 D
Other
0001419041-10-000003.rtf
0001419041-10-000003.pdf
10/05/10 D/A
Other
0001419041-10-000004.rtf
0001419041-10-000004.pdf
01/04/11 D
Other
0001419041-11-000001.rtf
0001419041-11-000001.pdf

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
2019 © Tocagen | Privacy Policy | Terms of Use
  • Facebook
  • Twitter
  • Youtube
  • Linkedin
Scroll to top